Clinical Trials Browser

Withdrawn × Brain Neoplasms × Bevacizumab × Clear all

NCT02348255 2018-01-09

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Phase 2 Withdrawn

Brain Neoplasms

NCT02065466 2016-04-21

Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases

Phase 1/2 Withdrawn

CNSDermatologic

Brain Neoplasms, Melanoma